4.7 Article

Doxorubicin-Induced Thymus Senescence

Journal

JOURNAL OF PROTEOME RESEARCH
Volume 9, Issue 12, Pages 6232-6241

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/pr100465m

Keywords

Doxorubicin; thymus; proteomics; ultrastructure; senescence

Funding

  1. University of Kentucky Markey Cancer Center

Ask authors/readers for more resources

Doxorubicin (DOX) is an anticancer drug used for the treatment of solid tumors The ability of DOX to treat cancer is not specific to cancer cells, some of the cells that are normal may also become targets of DOX, thereby altering the normal cellular functions and eventual cell loss DOX effects have been studied in detail in heart because of its ability to cause cardiomyopathy The exact mechanism of DOX induced cardiomyopathy is not completely understood One of organs that can be affected by DOX is thymus DOX treatment leads to degeneration of thymus however, since thymus undergoes age-dependent degeneration, researchers have understudied the effect of DOX on thymus In the present investigation we studied the effects of DOX on thymus an organ that is important for the T-cell maturation DOX treatment led to loss of cortical cells decrease lymphopoiesis and increased the number of Hassells corpuscles, a marker of thymus aging Proteomics analysis led to identification of a number of thymic proteins whose expression are altered by in vivo DOX treatment Taken together these results are consistent with the notion that DOX-treatment leads to thymic senescence

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Neurosciences

Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention

Chiara Lanzillotta, Ilaria Zuliani, Antonella Tramutola, Eugenio Barone, Carla Blarzino, Valentina Folgiero, Matteo Caforio, Diletta Valentini, Alberto Villani, Franco Locatelli, D. Allan Butterfield, Elizabeth Head, Marzia Perluigi, Jose F. Abisambra, Fabio Di Domenico

Summary: Abnormal activation of the PERK pathway in neurodegenerative disorders is associated with reduced protein synthesis, cell death, and altered antioxidant response. In Down syndrome, PERK activation is linked to the early development of Alzheimer's disease, suggesting that dysregulation of the PERK pathway may play a key role in DS pathology.

PROGRESS IN NEUROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

Broad Kinase Inhibition Mitigates Early Neuronal Dysfunction in Tauopathy

Shon A. Koren, Matthew J. Hamm, Ryan Cloyd, Sarah N. Fontaine, Emad Chishti, Chiara Lanzillotta, Jennifer Rodriguez-Rivera, Alexandria Ingram, Michelle Bell, Sara M. Galvis-Escobar, Nicholas Zulia, Fabio Di Domenico, Duc Duong, Nicholas T. Seyfried, David Powell, Moriel Vandsburger, Tal Frolinger, Anika M. S. Hartz, John Koren, Jeffrey M. Axten, Nicholas J. Laping, Jose F. Abisambra

Summary: Tauopathies are a group of disorders involving neurodegeneration and cognitive decline, with limited therapeutic options due to lack of understanding of molecular mechanisms. Treating early stage tau transgenic mice with a multi-target kinase inhibitor improved brain atrophy and cognitive function, despite unchanged levels of hyperphosphorylated tau. Proteomics data identified potential therapeutic targets for tauopathy treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Clinical Neurology

The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome

Ilaria Zuliani, Chiara Lanzillotta, Antonella Tramutola, Antonio Francioso, Sara Pagnotta, Eugenio Barone, Marzia Perluigi, Fabio Di Domenico

Summary: Protein O-GlcNAcylation plays a crucial role in neurodegenerative diseases, particularly in the pathogenesis of Alzheimer's disease. Although Down syndrome (DS) and AD share similar pathological features, the impact of O-GlcNAcylation in DS pathology has not been investigated. This study sheds light on the role of O-GlcNAcylation in DS brain alterations and its significance in AD hallmarks.

NEUROTHERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome

Chiara Lanzillotta, Antonella Tramutola, Graziella Di Giacomo, Federico Marini, D. Allan Butterfield, Fabio Di Domenico, Marzia Perluigi, Eugenio Barone

Summary: Research has shown that Down syndrome shares many common features with early onset Alzheimer's disease, including defects in brain insulin resistance, oxidative stress, and protein activation status in synaptic plasticity mechanisms. These abnormalities appear early in DS model mice, which may contribute to the development of AD in DS.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Biochemistry & Molecular Biology

Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules

Chiara Lanzillotta, Fabio Di Domenico

Summary: Down syndrome is characterized by early onset Alzheimer's disease due to triplication of genes on chromosome 21, leading to oxidative stress and protein oxidation. Therapeutic approaches targeting antioxidant response and protein stability have shown efficacy in murine models, but further studies are needed for clinical translation.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer's Disease Signatures

Ilaria Zuliani, Chiara Lanzillotta, Antonella Tramutola, Eugenio Barone, Marzia Perluigi, Serena Rinaldo, Alessio Paone, Francesca Cutruzzola, Francesco Bellanti, Matteo Spinelli, Francesca Natale, Salvatore Fusco, Claudio Grassi, Fabio Di Domenico

Summary: This study reveals that aberrant protein O-GlcNAcylation plays a significant role in the neurodegenerative process induced by a high-fat diet, potentially promoting the development of Alzheimer's disease and mitochondrial impairment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Clinical Neurology

Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles

Marzia Perluigi, Anna Picca, Elita Montanari, Riccardo Calvani, Federico Marini, Roberto Matassa, Antonella Tramutola, Alberto Villani, Giuseppe Familiari, Fabio Di Domenico, D. Allan Butterfield, Kenneth J. Oh, Emanuele Marzetti, Diletta Valentini, Eugenio Barone

Summary: The study found that nEVs isolated from DS children showed a significant increase in insulin resistance marker pIRS1(Ser636) and hyperactivation of the Akt/mTOR/p70S6K pathway downstream from IRS1, possibly driven by higher inhibition of PTEN. Additionally, high levels of pGSK3 beta(Ser9) were also observed. These alterations in the insulin-signaling/mTOR pathways are believed to be early events in the DS brain, contributing to the cognitive dysfunction and intellectual disability seen in this unique population.

ALZHEIMERS & DEMENTIA (2022)

Meeting Abstract Biochemistry & Molecular Biology

The Interplay Among Oxidative Stress, Brain Insulin Resistance and AMPK Dysfunction Contribute to Neurodegeneration in Type 2 Diabetes and Alzheimer Disease

D. Allan Butterfield, Eugenio Barone, Fabio Di Domenico, Marzia Perluigi

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Biochemistry & Molecular Biology

CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome

Sara Pagnotta, Antonella Tramutola, Eugenio Barone, Fabio Di Domenico, Valeria Pittala, Loredana Salerno, Valentina Folgiero, Matteo Caforio, Franco Locatelli, Stefania Petrini, D. Allan Butterfield, Marzia Perluigi

Summary: This study focuses on the role of BACH1/NRF2 ratio in the regulation of antioxidant response and its impact on patients with Down syndrome. The results show that overexpression of BACH1 disrupts the induction of antioxidant response genes, leading to oxidative damage accumulation. Additionally, administration of CAPE and VP961 promotes NRF2 nuclear translocation in cells from Down syndrome patients, improving antioxidant response.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Meeting Abstract Biochemistry & Molecular Biology

Loss Of Biliverdin Reductase-A (BVR-A) Impairs Brain Energy Metabolism Favoring The Development Of Neurodegeneration: A Link Between AD And T2DM

Chiara Lanzillotta, Antonella Tramutola, Fabio Di Domenico, Bindu Paul, Solomon Snyder, D. Allan Butterfield, Marzia Perluigi, Joao Duarte, Eugenio Barone

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Meeting Abstract Biochemistry & Molecular Biology

The harmful relationship between redox homeostasis and protein quality control systems in Alzheimer-like pathology

Fabio Di Domenico, Chiara Lanzillotta, Eugenio Barone, Antonella Tramutola, Marzia Perluigi

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Meeting Abstract Biochemistry & Molecular Biology

Intranasal Insulin Administration Reduces Oxidative Stress-Induced Damage And Improves Mitochondrial Bioenergetics In Alzheimer Disease

Antonella Tramutola, Sara Pagnotta, Fabio Di Domenico, Marzia Perluigi, Eugenio Barone

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Neurosciences

Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome

Chiara Urbinati, Chiara Lanzillotta, Livia Cosentino, Daniela Valenti, Maria Cristina Quattrini, Livia Di Crescenzo, Francesca Prestia, Donatella Pietraforte, Marzia Perluigi, Fabio Di Domenico, Rosa Anna Vacca, Bianca De Filippis

Summary: Metformin treatment can selectively correct cognitive flexibility defects, improve mitochondrial function, and inhibit oxidative stress in female mice with Rett syndrome (RTT). However, it does not affect the general health and motor skills of RTT mice.

NEUROPHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer's Disease-like Neuropathology in a Mouse Model for Down Syndrome

Antonella Tramutola, Simona Lanzillotta, Giuseppe Aceto, Sara Pagnotta, Gabriele Ruffolo, Pierangelo Cifelli, Federico Marini, Cristian Ripoli, Eleonora Palma, Claudio Grassi, Fabio Di Domenico, Marzia Perluigi, Eugenio Barone

Summary: Down syndrome (DS) is associated with Alzheimer's disease (AD) and brain insulin resistance. The KYCCSRK peptide has shown potential for improving insulin signaling in DS and reducing AD-like neuropathology in mice.

ANTIOXIDANTS (2023)

Meeting Abstract Biochemistry & Molecular Biology

DECIPHERING THE NOXIOUS RELATIONSHIP BETWEEN OXIDATIVE STRESS AND THE UNFOLDED PROTEIN RESPONSE IN ALZHEIMER-LIKE NEUROPATHOLOGY

Fabio Di Domenico

FREE RADICAL BIOLOGY AND MEDICINE (2022)

No Data Available